Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions

Abstract Indocyanine green (ICG) is a diagnostic dye commonly used in medical imaging and liver function monitoring. Given its widespread use, there is a need for detailed evaluations of its adverse drug reactions in real-world settings. As the comprehensive overview of its safety profile is very li...

Full description

Saved in:
Bibliographic Details
Main Authors: Yan Jiao, Yahui Liu, Meng Jin
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-81903-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846137037378289664
author Yan Jiao
Yahui Liu
Meng Jin
author_facet Yan Jiao
Yahui Liu
Meng Jin
author_sort Yan Jiao
collection DOAJ
description Abstract Indocyanine green (ICG) is a diagnostic dye commonly used in medical imaging and liver function monitoring. Given its widespread use, there is a need for detailed evaluations of its adverse drug reactions in real-world settings. As the comprehensive overview of its safety profile is very limited, this study aimed to analyze the adverse events (AEs) associated with ICG using data from the Food and Drug Administration Adverse Event Reporting System (FAERS). Data between 2004Q1 and 2023Q4 were extracted from the FAERS database. Signal detection was performed using various disproportionality analysis algorithms, including reporting odds ratio (ROR), proportional reporting ratio, Bayesian confidence propagation neural network, and multiitem gamma Poisson shrinker. During the study period, a total of 62 ICG-related AEs were reported in the FAERS database. Significant clinical adverse reactions included anaphylactic shock (ROR: 92.10, 95% confidence interval (CI): 37.71-224.96), procedural hypotension (ROR: 1397.27, 95% CI: 443.31-4404.08), and urticaria (ROR: 10.88, 95% CI: 4.02–29.42). This study provides valuable insights into the safety profile of ICG, highlighting the need for further monitoring to ensure its safe clinical use in clinical practice. Ongoing pharmacovigilance and large-scale studies are warranted to fully understand the potential risks associated with ICG.
format Article
id doaj-art-2d9fae1ba3314effab9eaf989c6adce6
institution Kabale University
issn 2045-2322
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-2d9fae1ba3314effab9eaf989c6adce62024-12-08T12:30:42ZengNature PortfolioScientific Reports2045-23222024-12-0114111010.1038/s41598-024-81903-zExploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactionsYan Jiao0Yahui Liu1Meng Jin2Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin UniversityDepartment of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin UniversityDepartment of Radiation Oncology, Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin UniversityAbstract Indocyanine green (ICG) is a diagnostic dye commonly used in medical imaging and liver function monitoring. Given its widespread use, there is a need for detailed evaluations of its adverse drug reactions in real-world settings. As the comprehensive overview of its safety profile is very limited, this study aimed to analyze the adverse events (AEs) associated with ICG using data from the Food and Drug Administration Adverse Event Reporting System (FAERS). Data between 2004Q1 and 2023Q4 were extracted from the FAERS database. Signal detection was performed using various disproportionality analysis algorithms, including reporting odds ratio (ROR), proportional reporting ratio, Bayesian confidence propagation neural network, and multiitem gamma Poisson shrinker. During the study period, a total of 62 ICG-related AEs were reported in the FAERS database. Significant clinical adverse reactions included anaphylactic shock (ROR: 92.10, 95% confidence interval (CI): 37.71-224.96), procedural hypotension (ROR: 1397.27, 95% CI: 443.31-4404.08), and urticaria (ROR: 10.88, 95% CI: 4.02–29.42). This study provides valuable insights into the safety profile of ICG, highlighting the need for further monitoring to ensure its safe clinical use in clinical practice. Ongoing pharmacovigilance and large-scale studies are warranted to fully understand the potential risks associated with ICG.https://doi.org/10.1038/s41598-024-81903-zIndocyanine greenAdverse drug reactionsFAERS databasePharmacovigilanceSignal detection
spellingShingle Yan Jiao
Yahui Liu
Meng Jin
Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
Scientific Reports
Indocyanine green
Adverse drug reactions
FAERS database
Pharmacovigilance
Signal detection
title Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
title_full Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
title_fullStr Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
title_full_unstemmed Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
title_short Exploring the dark side of diagnostic dyes with a focus on Indocyanine green’s adverse reactions
title_sort exploring the dark side of diagnostic dyes with a focus on indocyanine green s adverse reactions
topic Indocyanine green
Adverse drug reactions
FAERS database
Pharmacovigilance
Signal detection
url https://doi.org/10.1038/s41598-024-81903-z
work_keys_str_mv AT yanjiao exploringthedarksideofdiagnosticdyeswithafocusonindocyaninegreensadversereactions
AT yahuiliu exploringthedarksideofdiagnosticdyeswithafocusonindocyaninegreensadversereactions
AT mengjin exploringthedarksideofdiagnosticdyeswithafocusonindocyaninegreensadversereactions